Chinese medicine neuroaid efficacy on stroke recovery: A double-blind, placebo-controlled, randomized study

Stroke

Volumn 44, Issue 8, 2013, Pages 2093-2100

  Chen, Christopher L H ^a   Young, Sherry H Y ^b   Gan, Herminigildo H ^c   Singh, Rajinder ^d   Lao, Annabelle Y ^e   Baroque, Alejandro C ^f   Chang, Hui Meng ^g   Hiyadan, John Harold B ^h   Chua, Carlos L ⁱ   Advincula, Joel M ^j   Muengtaweepongsa, Sombat ^k   Chan, Bernard P L ^l   De Silva, H Asita ^m   Towanabut, Somchai ⁿ   Suwanwela, Nijasri C ^o   Poungvarin, Niphon ^p   Chankrachang, Siwaporn ^q   Wong, K S Lawrence ^r   Eow, Gaik Bee ^s   Navarro, Jose C ^f   Venketasubramanian, Narayanaswamy ^t   Lee, Chun Fan ^u   Bousser, Marie Germaine ^v   more..

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b CHANGI GENERAL HOSPITAL   (Singapore)

^c Jose R Reyes Memorial Medical Center   (Philippines)

^d National Neuroscience Institute   (Singapore)

^e San Pedro Hospital   (Philippines)

^f UNIVERSITY OF SANTO TOMAS HOSPITAL   (Philippines)

^g SINGAPORE GENERAL HOSPITAL   (Singapore)

^h Baguio General Hospital   (Philippines)

ⁱ UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^j WEST VISAYAS STATE UNIVERSITY   (Philippines)

^k THAMMASAT UNIVERSITY   (Thailand)

^l NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^m UNIVERSITY OF KELANIYA   (Sri Lanka)

ⁿ PRASAT NEUROLOGICAL INSTITUTE   (Thailand)

^o CHULALONGKORN UNIVERSITY   (Thailand)

^p MAHIDOL UNIVERSITY   (Thailand)

^q CHIANG MAI UNIVERSITY   (Thailand)

^r CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^s HOSPITAL PULAU PINANG   (Malaysia)

^t RAFFLES HOSPITAL   (Singapore)

^u SINGAPORE CLINICAL RESEARCH INSTITUTE   (Singapore)

^v HÔPITAL LARIBOISIÈRE   (France)

more..

Author keywords

clinical trial; medicine, Chinese traditional; NeuroAiD; recovery of function; stroke, acute

Indexed keywords

ANTICOAGULANT AGENT; CENTRAL NERVOUS SYSTEM AGENTS; CHINESE DRUG; HERBACEOUS AGENT; MLC 601; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BARTHEL INDEX; CEREBROVASCULAR ACCIDENT; CHINESE MEDICINE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MULTICENTER STUDY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; UNSPECIFIED SIDE EFFECT;

CLINICAL TRIAL; MEDICINE, CHINESE TRADITIONAL; NEUROAID; RECOVERY OF FUNCTION; STROKE, ACUTE;

ACUTE DISEASE; AGED; DOUBLE-BLIND METHOD; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; ODDS RATIO; SEVERITY OF ILLNESS INDEX; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84880803598     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.002055     Document Type: Article

References (30)

1. European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee: Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008;25:457-507.
2. Ginsberg MD. Current status of neuroprotection for cerebral ischemia: synoptic overview. Stroke. 2009;40(3 Suppl):S111-S114.
3. Pandian JD, Liu M, Misbach J, Venketasubramanian N. Alternative therapies for stroke treatment in Asia. Int J Stroke. 2011;6:541-543.
4. Rausch WD, Liu S, Gille G, Radad K. Neuroprotective effects of ginsen-osides. Acta Neurobiol Exp (Wars). 2006;66:369-375.
5. Bei W, Peng W, Zang L, Xie Z, Hu D, Xu A. Neuroprotective effects of a standardized extract of Diospyros kaki leaves on MCAO transient focal cerebral ischemic rats and cultured neurons injured by glutamate or hypoxia. Planta Med. 2007;73:636-643. (Pubitemid 47066155)
6. Wu B, Liu M, Liu H, Li W, Tan S, Zhang S, et al. Meta-analysis of traditional Chinese patent medicine for ischemic stroke. Stroke. 2007;38:1973-1979. (Pubitemid 46847279)
7. Junhua Z, Menniti-Ippolito F, Xiumei G, Firenzuoli F, Boli Z, Massari M, et al. Complex traditional Chinese medicine for poststroke motor dysfunction: a systematic review. Stroke. 2009;40:2797-2804.
8. Heurteaux C, Gandin C, Borsotto M, Widmann C, Brau F, Lhuillier M, et al. Neuroprotective and neuroproliferative activities of NeuroAid (MLC601, MLC901), a Chinese medicine, in vitro and in vivo. Neuropharmacology. 2010;58:987-1001.
9. Quintard H, Borsotto M, Veyssiere J, Gandin C, Labbal F, Widmann C, et al. MLC901, a traditional Chinese medicine protects the brain against global ischemia. Neuropharmacology. 2011;61:622-631.
10. Moha Ou Maati H, Borsotto M, Chatelain F, Widmann C, Lazdunski M, Heurteaux C. Activation of ATP-sensitive potassium channels as an element of the neuroprotective effects of the Traditional Chinese Medicine MLC901 against oxygen glucose deprivation. Neuropharmacology. 2012;63:692-700.
11. Chen C, Venketasubramanian N, Gan RN, Lambert C, Picard D, Chan BP, et al. Danqi Piantang Jiaonang (DJ), a traditional Chinese medicine, in poststroke recovery. Stroke. 2009;40:859-863.
12. Harandi AA, Abolfazli R, Hatemian A, Ghragozlee K, Ghaffar-Pour M, Karimi M, et al. Safety and effcacy of MLC601 in Iranian patients after stroke: a double-blind, placebo-controlled clinical trial. StrokeRes Treat. 2011;2011:721613.
13. Kong KH, Wee SK, Ng CY, Chua K, Chan KF, Venketasubramanian N, et al. A double-blind, placebo-controlled, randomized phase II pilot study to investigate the potential effcacy of the traditional Chinese medicine Neuroaid (MLC 601) in enhancing recovery after stroke (TIERS). Cerebrovasc Dis. 2009;28:514-521.
14. Bavarsad Shahripour R, Shamsaei G, Pakdaman H, Majdinasab N, Nejad EM, Sajedi SA, et al. The effect of NeuroAiD™ (MLC601) on cerebral blood fow velocity in subjects' post brain infarct in the middle cerebral artery territory. Eur J Intern Med. 2011;22:509-513.
15. Ghandehari K, Mood ZI, Ebrahimzadeh S, Picard D, Zhang Y. NeuroAid (MLC601) versus piracetam in the recovery of post-infarct homonymous hemianopsia. Neural Regener Res. 2011;6: 418-422.
16. Navarro JC, Molina MC, Baroque Ii AC, Lokin JK. The use of NeuroAiD (MLC601) in postischemic stroke patients. Rehabil Res Pract. 2012;2012:506387.
17. Siow CH. Neuroaid in stroke recovery. Eur Neurol. 2008;60:264-266.
18. Young SHY, Zhao Y, Koh A, Singh R, Chan BP, Chang HM et al. Safety profle of MLC601 (Neuroaid) in acute ischemic stroke patients: a Singaporean substudy on the Chinese Medicine Neuroaid effcacy on Stroke Recovery Study. Cerebrovasc Dis. 2010;30:1-6.
19. Gan R, Lambert C, Lianting J, Chan ES, Venketasubramanian N, Chen C, et al. Danqi Piantan Jiaonang does not modify hemostasis, hematology, and biochemistry in normal subjects and stroke patients. Cerebrovasc Dis. 2008;25:450-456. (Pubitemid 351754642)
20. Venketasubramanian N, Chen CL, Gan RN, Chan BP, Chang HM, Tan SB, et al.; CHIMES Investigators. A double-blind, placebo-controlled, randomized, multicenter study to investigate CHInese Medicine Neuroaid Effcacy on Stroke recovery (CHIMES Study). Int J Stroke. 2009;4:54-60.
21. Wong KS, Chen C, Ng PW, Tsoi TH, Li HL, Fong WC, et al; FISS-tris Study Investigators. Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study. Lancet Neurol. 2007;6:407-413. (Pubitemid 46551851)
22. Shuaib A, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, et al; SAINT II Trial Investigators. NXY-059 for the treatment of acute isch-emic stroke. N Engl J Med. 2007;357:562-571. (Pubitemid 47236281)
23. Dávalos A, Alvarez-Sabín J, Castillo J, Díez-Tejedor E, Ferro J, Martínez-Vila E, et al; International Citicoline Trial on acUte Stroke (ICTUS) trial investigators. Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). Lancet. 2012;380:349-357.
24. Lees KR, Bornstein N, Diener HC, Gorelick PB, Rosenberg G, Shuaib A; MACSI Investigators. Results of membrane-activated chelator stroke intervention randomized trial of DP-b99 in acute ischemic stroke. Stroke. 2013;44:580-584.
25. Heiss WD, Brainin M, Bornstein NM, Tuomilehto J, Hong Z; Cerebrolysin Acute Stroke Treatment in Asia (CASTA) Investigators. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial. Stroke. 2012;43:630-636.
26. Hacke W, Furlan AJ, Al-Rawi Y, Davalos A, Fiebach JB, Gruber F, et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol. 2009;8:141-150.
27. Siddiqui FJ, Venketasubramanian N, Chan ES, Chen C. Effcacy and safety of MLC601 (NeuroAiD®), a traditional Chinese medicine, in poststroke recovery: a systematic review. Cerebrovasc Dis. 2013;35(Suppl 1):8-17.
28. Lo EH. A new penumbra: transitioning from injury into repair after stroke. Nat Med. 2008;14:497-500. (Pubitemid 351655209)
29. Duncan PW, Goldstein LB, Matchar D, Divine GW, Feussner J. Measurement of motor recovery after stroke. Outcome assessment and sample size requirements. Stroke. 1992;23:1084-1089.
30. Venketasubramanian N, Young S, Tay SS, Chang HM, Umapathi T, Chan B, et al. Chinese medicine NeuroAiD effcacy stroke recovery-extension study (CHIMES-E study): an observational multicenter study to investigate the longer-term effcacy of NeuroAiD in stroke recovery. Cerebrovasc Dis. 2013;35(Suppl 1):18-22.